Miriam H. Huntley, PhD

Chief Technology Officer & Co-Founder
Day Zero Diagnostics
Boston, MA, United States

Disclosure(s): Day Zero Diagnostics: Employee/Salary (Ongoing), Ownership Interest (Ongoing)

Presentation(s):

• 966 - Large-Scale Evaluation of AST Prediction using Resistance Marker Presence/Absence vs. Machine Learning on WGS Data

  Thursday, October 12, 2023
  1:57 PM – 2:09 PM US ET

• 1041 - Keynome gAST (Genomic Antimicrobial Susceptibility Testing): Whole Genome Sequencing and Machine Learning for Accurate Resistance Determination; Day Zero Diagnostics

  Friday, October 13, 2023
  8:45 AM – 9:00 AM US ET